BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
34 hedge funds and large institutions have $560K invested in BRAINSTORM CELL THERAPUTC in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
78% less capital invested
Capital invested by funds: $2.52M → $560K (-$1.96M)
Holders
34
Holding in Top 10
–
Calls
$23K
Puts
–
Top Buyers
| 1 | +$45K | |
| 2 | +$22.7K | |
| 3 | +$15.8K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$13.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.5K |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$50.5K | |
| 3 | -$34K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$27K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$25.9K |